Persistence of high-capacity adenoviral vectors as replication-defective monomeric genomes in vitro and in murine liver

Human Gene Therapy

Volumn 20, Issue 8, 2009, Pages 883-896

  Jager, Lorenz ^a   Ehrhardt, Anja ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; MONOMER; VIRUS DNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE REPLICATION; GENE THERAPY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; VIRUS GENOME;

ADENOVIRIDAE; ANIMALS; CELL CYCLE; CELL LINE; DNA RESTRICTION ENZYMES; DNA, CONCATENATED; ELECTROPHORESIS, GEL, PULSED-FIELD; GENETIC VECTORS; GENOME, VIRAL; HUMANS; LIVER; MICE; MICE, INBRED C57BL; POLYMERASE CHAIN REACTION; VIRUS REPLICATION;

ADENOVIRIDAE; CANIS FAMILIARIS; MURINAE; MUS; PRIMATES; RATTUS;

EID: 68949201560     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2009.020     Document Type: Article

References (44)

1. Allen, C., Halbrook, J., and Nickoloff, J.A. (2003). Interactive competition between homologous recombination and non-homologous end joining. Mol. Cancer Res. 1, 913-920.
2. Belalcazar, L.M., Merched, A., Carr, B., Oka, K., Chen, K.H., Pastore, L., Beaudet, A., and Chan, L. (2003). Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia. Circulation 107, 2726-2732.
3. Boyer, J., Rohleder, K., and Ketner, G. (1999). Adenovirus E4 34k and E4 11k inhibit double strand break repair and are physically associated with the cellular DNA-dependent protein kinase. Virology 263, 307-312.
4. Bridge, E., and Ketner, G. (1989). Redundant control of adenovirus late gene expression by early region 4. J. Virol. 63, 631-638.
5. Brunetti-Pierri, N., Stapleton, G.E., Palmer, D.J., Zuo, Y., Mane, V.P., Finegold, M.J., Beaudet, A.L., Leland, M.M., Mullins C.E., and Ng, P. (2007). Pseudo-hydrodynamic delivery of helper-dependent adenoviral vectors into non-human primates for liver-directed gene therapy. Mol. Ther. 15, 732-740.
6. Brunetti-Pierri, N., Stapleton, G.S., Law, M., Breinholt, J., Palmer, D.J., Zuo, Y., Grove, N.C., Finegold, M.J., Rice, K., Beaudet, A.L., Mullins, C.E., and Ng, P. (2009). Efficient, long-term hepatic gene transfer using clinically relevant HDAd doses by balloon occlusion catheter delivery in nonhuman primates. Mol. Ther. 17, 327-333.
7. 2/M checkpoint. EMBO J. 22, 6610-6620.
8. Chen, Z.Y., He, C.Y., Ehrhardt, A., and Kay, M.A. (2003). Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo. Mol. Ther. 8, 495-500.
9. de Jong, R.N., and van der Vliet, P.C. (1999). Mechanism of DNA replication in eukaryotic cells: Cellular host factors stimulating adenovirus DNA replication. Gene 236, 1-12.
10. Ehrhardt, A., and Kay, M.A. (2002). A new adenoviral helper-dependent vector results in long-term therapeutic levels of human coagulation factor IX at low doses in vivo. Blood 99, 3923-3930.
11. Ehrhardt, A., Xu, H., Dillow, A.M., Bellinger, D.A., Nichols, T.C., and Kay, M.A. (2003a). A gene-deleted adenoviral vector results in phenotypic correction of canine hemophilia B without liver toxicity or thrombocytopenia. Blood 102, 2403-2411.
12. Ehrhardt, A., Xu, H., and Kay, M.A. (2003b). Episomal persistence of recombinant adenoviral vector genomes during the cell cycle in vivo. J. Virol. 77, 7689-7695.
13. Ehrhardt, A., Yant, S.R., Giering, J.C., Xu, H., Engler, J.A., and Kay, M.A. (2007). Somatic integration from an adenoviral hybrid vector into a hot spot in mouse liver results in persistent transgene expression levels in vivo. Mol. Ther. 15, 146-156.
14. Ehrhardt, A., Haase, R., Schepers, A., Deutscher, M., Lipps, H.J., and Baiker, A. (2008). Episomal vectors for gene therapy. Curr. Gene Ther. 8, 147-161.
15. Fukuhara, Y., Hirasawa, A., Li, X.K., Kawasaki, M., Fujino, M., Funeshima, N., Katsuma, S., Shiojima, S., Yamada, M., Okuyama, T., Suzuki, S., and Tsujimoto, G. (2003). Gene expression profile in the regenerating rat liver after partial hepatectomy. J. Hepatol. 38, 784-792.
16. Gingeras, T.R., and Brooks, J.E. (1983). Cloned restriction/modification system from Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U.S.A. 80, 402-406.
17. Jager, L., and Ehrhardt, A. (2007). Emerging adenoviral vectors for stable correction of genetic disorders. Curr. Gene Ther. 7, 272-283.
18. Jager, L., Haeusl, M., Rauschhuber, C., Wolf, N.M., and Ehrhardt, A. (2009). A rapid protocol for construction and production of gene-deleted adenoviral vectors. Nat. Protoc. 4, 547-564.
19. Jayaram, S., and Bridge, E. (2005). Genome concatenation contributes to the late gene expression defect of an adenovirus E4 mutant. Virology 342, 286-296.
20. Jozkowicz, A., and Dulak, J. (2005). Helper-dependent adenoviral vectors in experimental gene therapy. Acta Biochim. Pol. 5, 589-599.
21. Kim, I.H., Jozkowicz, A., Piedra, P.A., Oka, K., and Chan, L. (2001). Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector. Proc. Natl. Acad. Sci. U.S.A. 98, 13282-13287.
22. Kreppel, F., and Kochanek, S. (2004). Long-term transgene expression in proliferating cells mediated by episomally maintained high-capacity adenovirus vectors. J. Virol. 78, 9-22.
23. Kreppel, F., Luther, T.T., Semkova, I., Schraermeyer, U., and Kochanek, S. (2002). Long-term transgene expression in the RPE after gene transfer with a high-capacity adenoviral vector. Invest. Ophthalmol. Vis. Sci. 43, 1965-1970.
24. Leahy, P., Carmichael, G.G., and Rossomando, E.F. (1997). Transcription from plasmid expression vectors is increased up to 14-fold when plasmids are transfected as concatemers. Nucleic Acids Res. 25, 449-450.
25. Miao, C.H., Snyder, R.O., Schowalter, D.B., Patijn, G.A., Donahue, B., Winther, B., and Kay, M.A. (1998). The kinetics of rAAV integration in the liver. Nat. Genet. 19, 13-15.
26. Miao, C.H., Ohashi, K., Patijn, G.A., Meuse, L., Ye, X., Thompson, A.R., and Kay, M.A. (2000). Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro. Mol. Ther. 1, 522-532.
27. Morral, N., Parks, R.J., Zhou, H., Langston, C., Schiedner, G., Quinones, J., Graham, F.L., Kochanek, S., and Beaudet, A.L. (1998). High doses of a helper-dependent adenoviral vector yield supraphysiological levels of a1-antitrypsin with negligible toxicity. Hum. Gene Ther. 18, 2709-2716.
28. Morral, N., O'Neal, W., Rice, K., Leland, M., Kaplan, J., Piedra, P.A., Zhou, H., Parks, R.J., Velji, R., Aguilar-Córdova, E., Wadsworth, S., Graham, F.L., Kochanek, S., Carey, K.D., and Beaudet, A.L. (1999). Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons. Proc. Natl. Acad. Sci. U.S.A. 96, 12816-12821.
29. Nakai, H., Storm, T.A., and Kay, M.A. (2000). Recruitment of single-stranded recombinant adeno-associated virus vector genomes and intermolecular recombination are responsible for stable transduction of liver in vivo. J. Virol. 74, 9451-9463.
30. Nelson, J.E., and Kay, M.A. (1997). Persistence of recombinant adenovirus in vivo is not dependent on vector DNA replication. J. Virol. 71, 8902-8907.
31. Ozer, J., Ratner, M., Shaw, M., Bailey, W., and Schomaker, S. (2008). The current state of serum biomarkers of hepatotoxicity. Toxicology 245, 194-205.
32. Palmer, D., and Ng, P. (2003). Improved system for helper-dependent adenoviral vector production. Mol. Ther. 8, 846-852.
33. Parks, R.J., Bramson, J.L., Wan, Y., Addison, C.L., and Graham, F.L. (1999). Effects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors. J. Virol. 73, 8027-8034.
34. Puntel, M., Curtin, J.F., Zirger, J.M., Muhammad, A.K.M., Xiong, W., Liu, C., Hu, J., Kroeger, K.M., Czer, P., Sciascia, S., Mondkar, S., Lowenstein, P.R., and Castro, M.G., (2006). Quantification of high-capacity helper-dependent adenoviral vector genomes in vitro and in vivo, using quantitative Taq-Man real-time polymerase chain reaction. Hum. Gene Ther. 17, 531-544.
35. Rauschhuber, C., Xu, H., Salazar, F.H., Marion, L.P., and Ehrhardt, A. (2008). Exploring gene-deleted adenoviral vectors for delivery of short hairpin RNAs and reduction of hepatitis B virus infection in mice. J. Gene Med. 10, 878-889.
36. Ruben, M., Bacchetti, S., and Graham, F. (1983). Covalently closed circles of adenovirus type 5 DNA. Nature 301, 172-174.
37. Sandler, A.B., and Ketner, G. (1989). Adenovirus early region 4 is essential for normal stability of late nuclear RNAs. J. Virol. 63, 624-630.
38. Schiedner, G., Morral, N., Parks, R.J., Wu, Y., Koopmans, S.C., Langston, C., Graham, F.L., Beaudet, A.L., and Kochanek, S. (1998). Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat. Genet. 18, 180-183.
39. Stracker, T.H., Carson, C.T., and Weitzman, M.D. (2002). Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature 418, 348-352.
40. Stracker, T.H., Lee, D.V., Carson, C.T., Araujo, F.D., Ornelles, D.A., and Weitzman, M.D. (2005). Serotype-specific reorganization of the Mre11 complex by adenoviral E4orf3 proteins. J. Virol. 79, 6664-6673.
41. Toietta, G., Mane, V.P., Norona, W.S., Finegold, M.J., Ng, P., McDonagh, A.F., Beaudet, A.L., and Lee, B. (2005). Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector. Proc. Natl. Acad. Sci. U.S.A. 102, 3930-3935.
42. Weber, L.W., Boll, M., and Stampfl, A. (2003). Hepatotoxicity and mechanism of action of haloalkanes: Carbon tetrachloride as a toxicological model. Crit. Rev. Toxicol. 33, 105-136.
43. Weiden, M.D., and Ginsberg, H.S. (1994). Deletion of the E4 region of the genome produces adenovirus DNA concatemers. Proc. Natl. Acad. Sci. U.S.A. 91, 153-157.
44. Weitzman, M.D. (2005). Functions of the adenovirus E4 proteins and their impact on viral vectors. Front. Biosci. 10, 1106-1117.